ReviewFrontiers in immunology2021

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma.

Darel Martínez Bedoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.